does medi-cal cover tirzepatide 📢 ACP Obesity Guidelines 2026 are here. For the first time, semaglutide and are recommended as co-first-line pharmacotherapy for obesity. #ACPGuidelines #ObesityMedicine #Semaglutide 🥇 THE NEW 4-TIER LADDER Tier 1: 💉 Mounjaro (Tirzepatide) for Medical Weight

When to seek urgent medical attention : Severe, persistent abdominal pain (particularly if radiating to the back) Bloody diarrhoea or significant increase in stool frequency Signs of dehydration (dizziness, reduced urine output, dry mouth) Persistent vomiting preventing oral intake Fever accompanying gastrointestinal symptoms Patients should contact their GP or IBD team promptly if they experience worsening symptoms that could indicate either a Crohn's flare or serious medication side effects

T.et al (2015)

Members can request guidance from a registered dietitian and connect with Weight Watchers experts for additional support

Two days early is the edge of the safe window

In clinical trials, less than 1% of people taking semaglutide reported experiencing constipation